Brief: Arcutis Announces Pricing Of $100 Million Public Offering
20/10/2023 04:51
Oct 19 (Reuters) - Arcutis Biotherapeutics Inc ARQT.O :
* ARCUTIS ANNOUNCES PRICING OF $100 MILLION PUBLIC OFFERING
* PRICES 32.5 MILLION SHARES OF COMMON STOCK OF AT $2.50 PER
SHARE
* PRICING OF PRE-FUNDED WARRANTS TO PURCHASE 7.5 MILLION
SHARES OF
COMMON STOCK AT $2.5 PER SHARE
Source text for Eikon: ID:nGNX2fF04c
Further company coverage: ARQT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arcutis Biotherapeutics
See all newsBrief: Arcutis Biotherapeutics reports inducement grants under Nasdaq listing rule 5635(C)(4
Arcutis Q1 product revenue rises 65% yr/yr, net loss narrows
Brief: Arcutis Announces Promotion Of MAS Matsuda To Executive Vice President And Chief Legal Officer To Support Next Phase Of Growth
Brief: Arcutis Begins Enrolling Phase 1A/1B Study Evaluating Arq-234, A Cd200r Agonist, In Healthy Volunteers And Adults With Atopic Dermatitis
Brief: Arcutis Biotherapeutics Inc Files For Mixed Shelf